The Pharmacologic Treatment of Acute Heart Failure.
- Author:
Hyungseop KIM
1
Author Information
1. Division of Cardiology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. khyungseop@dsmc.or.kr
- Publication Type:Review
- Keywords:
Acute heart failure;
Diuretics;
Vasodilators;
Inotropes
- MeSH:
Blood Pressure;
Cardiac Output;
Diuretics;
Emergencies;
Heart;
Heart Failure;
Hemodynamics;
Humans;
Morphine;
Vasodilator Agents
- From:Korean Journal of Medicine
2012;82(6):651-657
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Acute heart failure (HF) is commonly encountered in the emergency department and thus, the hospital admissions for worsening HF are increasing. However, the patients presenting with acute HF are heterogenous and complex at high risk of morbidity and mortality. The main goals of treatment for hospitalized patients with HF are to restore euvolemia and to maintain the hemodynamic status without causing adverse events. Currently, the recommendations are usually based on a clinical factor considering the initial systolic blood pressure and other symptoms. Accordingly, initial managements in the hospital generally include diuretics, vasodilators, morphine, and inotropic agents, all of which have been considered as traditional therapies. These agents should mainly increase cardiac output and improve symptoms, and importantly it should improve the clinical outcomes. The aim of this review is to describe the available and new pharmacologic drugs for patients presenting with acute HF.
